The results showed that the average size and weight of tumors in the NC group were clearly higher than those in the siRNA1-URG4 group (Fig. 2d), which indicates that silencing URG4 can inhibit the tumorigenic effects of osteosarcoma cells in vivo. Here, URGCP is linked to osteosarcoma.